Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum.

Creed RB, Menalled L, Casey B, Dave KD, Janssens HB, Veinbergs I, van der Hart M, Rassoulpour A, Goldberg MS.

Neuroscience. 2019 Jun 15;409:169-179. doi: 10.1016/j.neuroscience.2019.04.033. Epub 2019 Apr 25.

2.

Antipsychotic-like behavioral effects and cognitive enhancement by a potent and selective muscarinic M-sub-1 receptor agonist, AC-260584.

Vanover KE, Veinbergs I, Davis RE.

Behav Neurosci. 2008 Jun;122(3):570-5. doi: 10.1037/0735-7044.122.3.570.

PMID:
18513127
3.

ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.

Gardell LR, Vanover KE, Pounds L, Johnson RW, Barido R, Anderson GT, Veinbergs I, Dyssegaard A, Brunmark P, Tabatabaei A, Davis RE, Brann MR, Hacksell U, Bonhaus DW.

J Pharmacol Exp Ther. 2007 Aug;322(2):862-70. Epub 2007 May 22.

PMID:
17519387
4.

Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist.

Vanover KE, Weiner DM, Makhay M, Veinbergs I, Gardell LR, Lameh J, Del Tredici AL, Piu F, Schiffer HH, Ott TR, Burstein ES, Uldam AK, Thygesen MB, Schlienger N, Andersson CM, Son TY, Harvey SC, Powell SB, Geyer MA, Tolf BR, Brann MR, Davis RE.

J Pharmacol Exp Ther. 2006 May;317(2):910-8. Epub 2006 Feb 9.

PMID:
16469866
5.

The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine.

Weiner DM, Meltzer HY, Veinbergs I, Donohue EM, Spalding TA, Smith TT, Mohell N, Harvey SC, Lameh J, Nash N, Vanover KE, Olsson R, Jayathilake K, Lee M, Levey AI, Hacksell U, Burstein ES, Davis RE, Brann MR.

Psychopharmacology (Berl). 2004 Dec;177(1-2):207-16. Epub 2004 Jul 16.

PMID:
15258717
6.

Pharmacological characterization of AC-90179 [2-(4-methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride]: a selective serotonin 2A receptor inverse agonist.

Vanover KE, Harvey SC, Son T, Bradley SR, Kold H, Makhay M, Veinbergs I, Spalding TA, Weiner DM, Andersson CM, Tolf BR, Brann MR, Hacksell U, Davis RE.

J Pharmacol Exp Ther. 2004 Sep;310(3):943-51. Epub 2004 Apr 21.

PMID:
15102927
7.

Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein.

Van Uden E, Mallory M, Veinbergs I, Alford M, Rockenstein E, Masliah E.

J Neurosci. 2002 Nov 1;22(21):9298-304.

8.

Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis.

Veinbergs I, Everson A, Sagara Y, Masliah E.

J Neurosci Res. 2002 Feb 1;67(3):379-87.

PMID:
11813243
9.

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.

Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L.

Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12245-50. Epub 2001 Sep 25.

10.

Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.

Veinbergs I, Van Uden E, Mallory M, Alford M, McGiffert C, DeTeresa R, Orlando R, Masliah E.

Exp Neurol. 2001 Jul;170(1):15-26.

PMID:
11421580
11.

Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice.

Veinbergs I, Mallory M, Sagara Y, Masliah E.

Eur J Neurosci. 2000 Dec;12(12):4541-6.

PMID:
11122365
12.

Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity.

Veinbergs I, Mante M, Mallory M, Masliah E.

J Neural Transm Suppl. 2000;59:273-80.

PMID:
10961439
13.

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L.

Science. 2000 Feb 18;287(5456):1265-9.

14.

A role for apoE in regulating the levels of alpha-1-antichymotrypsin in the aging mouse brain and in Alzheimer's disease.

Licastro F, Campbell IL, Kincaid C, Veinbergs I, Van Uden E, Rockenstein E, Mallory M, Gilbert JR, Masliah E.

Am J Pathol. 1999 Sep;155(3):869-75.

15.

Synaptotagmin and synaptic transmission alterations in apolipoprotein E-deficient mice.

Veinbergs I, Mante M, Jung MW, Van Uden E, Masliah E.

Prog Neuropsychopharmacol Biol Psychiatry. 1999 Apr;23(3):519-31.

PMID:
10378234
16.

A novel role for receptor-associated protein in somatostatin modulation: implications for Alzheimer's disease.

Van Uden E, Veinbergs I, Mallory M, Orlando R, Masliah E.

Neuroscience. 1999;88(3):687-700.

PMID:
10363810
17.

Synaptic alterations in apolipoprotein E knockout mice.

Veinbergs I, Masliah E.

Neuroscience. 1999;91(1):401-3. No abstract available.

PMID:
10336088
18.

Differential neurotrophic effects of apolipoprotein E in aged transgenic mice.

Veinbergs I, Mallory M, Mante M, Rockenstein E, Gilbert JR, Masliah E.

Neurosci Lett. 1999 Apr 23;265(3):218-22.

PMID:
10327170
19.

Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice.

Masliah E, Armasolo F, Veinbergs I, Mallory M, Samuel W.

Pharmacol Biochem Behav. 1999 Feb;62(2):239-45.

PMID:
9972690
20.

Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice.

Veinbergs I, Jung MW, Young SJ, Van Uden E, Groves PM, Masliah E.

Neurosci Lett. 1998 Jun 19;249(2-3):71-4.

PMID:
9682819
21.

Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development.

Hsu LJ, Mallory M, Xia Y, Veinbergs I, Hashimoto M, Yoshimoto M, Thal LJ, Saitoh T, Masliah E.

J Neurochem. 1998 Jul;71(1):338-44.

22.

Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE.

Masliah E, Samuel W, Veinbergs I, Mallory M, Mante M, Saitoh T.

Brain Res. 1997 Mar 21;751(2):307-14.

PMID:
9099820
23.

Alterations in apolipoprotein E expression during aging and neurodegeneration.

Masliah E, Mallory M, Veinbergs I, Miller A, Samuel W.

Prog Neurobiol. 1996 Dec;50(5-6):493-503. Review.

PMID:
9015824
24.

Neurodegeneration in the central nervous system of apoE-deficient mice.

Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD.

Exp Neurol. 1995 Dec;136(2):107-22.

PMID:
7498401
25.

Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor.

Roch JM, Masliah E, Roch-Levecq AC, Sundsmo MP, Otero DA, Veinbergs I, Saitoh T.

Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7450-4.

Supplemental Content

Loading ...
Support Center